Nomos pulls IPO (initial public offering) because of market conditions:
This article was originally published in Clinica
Executive Summary
Nomos, which develops and markets products aimed at improving the safety and effectiveness of radiation treatment of cancerous tumours, has withdrawn its IPO because of current market conditions. The Sewickly, Pennsylvania-based company says its business is healthy, with growing revenues, is profitable and has a positive cash flow. It will re-evaluate its position when market conditions improve, said president and CEO John Manzetti.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.